ABSTRACT
Gastro-oesophageal reflux disease (GORD) is increasingly encountered, having an estimated prevalence of up to 20% in the Western hemisphere. 1 Antireflux surgery (ARS) for GORD is cost effective compared with medical management in the long term, 2 with laparoscopic ARS being the gold standard. 3, 4 Obesity has doubled globally in the last three decades, and epidemiological studies suggest an association between obesity and GORD 5 as a result of distorted pressure gradients across the gastro-oesophageal junction. 6 Consequently, ARS is increasingly being carried out on people with a higher body mass index (BMI). Evidence for outcomes of ARS on obese patients is conflicting in terms of its safety and efficacy. [7] [8] [9] [10] [11] This systematic review and meta-analysis was undertaken with a view to informing future practice.
Methods
A systematic electronic search was undertaken using PubMed, MEDLINE ® , Ovid ® , Cochrane Library and Google Scholar™ according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidance. 12 Search terms comprised "obesity" OR "high BMI" AND "antireflux surgery" OR "Nissen fundoplication" OR "fundoplication". All search terms were combined with Boolean operators and searched as both keywords and Medical Subject Headings. The results were reviewed by two independent researchers (AT and QMN). The last search date was 10 October 2016.
Inclusion and exclusion criteria
Studies were included in this review if they looked at the effect of BMI on the outcome of laparoscopic fundoplication. Case reports, letters, editorials, conference abstracts, nonEnglish articles and animal studies were excluded, as were studies investigating bariatric surgery as ARS.
Outcome measures
The World Health Organization classification of BMI was used: normal BMI 18.5-24.9kg/m 2 , overweight ≥25kg/m 2 and obese ≥30kg/m 2 . 13 Outcomes included operative time, conversion to open procedure, mean length of hospital stay, recurrence of acid reflux requiring reoperation and wrap migration. Data were also collected for preoperative assessment, including lower oesophageal pressure, total acid exposure time on 24-hour pH monitoring, DeMeester score, presence of Barrett's oesophagus, presence of reflux oesophagitis, type of fundoplication and follow-up duration.
Study selection
Two authors (AT and QMN) independently performed the search. Disagreements on study selection were resolved by consensus with the senior author (RG). If the issue of study selection was still not resolved, the lead author's (NH's) decision was considered final.
Statistical analysis
Statistical analysis was undertaken using RevMan version 5.3 (Nordic Cochrane Centre, Copenhagen, Denmark). Data were pooled and rate differences as well as standard mean differences (SMDs) with 95% confidence intervals (CIs) were calculated. The random effects model was used as the effects were expected to be heterogeneous owing to the variety of study populations and study designs included in the analysis.
14 Heterogeneity was tested using the I 2 statistic.
Quality assessment
The methodological index for non-randomised studies (MINORS) 15 was used to evaluate methodological quality and potential bias of included studies.
Results
Overall, 8,470 articles were identified. Following exclusion of duplicates, non-English articles and animal studies, 2,124 articles remained. The titles and abstracts were then reviewed, and a further 2,103 articles were excluded. Of the remaining 21 articles, 8 were excluded owing to being smaller case series and studies reporting inappropriate outcomes. Finally, 13 studies were left for review (Fig 1) . [7] [8] [9] [10] [11] [16] [17] [18] [19] [20] [21] [22] [23] No randomised controlled trials (RCTs) were identified.
Eight of the studies were prospective 7, 9, 10, 16, 18, 19, 21, 23 and five were retrospective. 8, 11, 17, 20, 22 Study and patient characteristics A total of 3,772 patients were included in the 13 studies. Seven studies reported on patients in all three categories of BMI, 7, 8, 10, 16, 18, 19, 23 three studies reported on patients with BMI <30kg/m 2 and BMI ≥30kg/m 2 , 9,17,20 and one study reported on patients with normal BMI and patients who were obese. 11 The mean or median age was reported in six studies. 7, 10, 16, 20, 21, 23 There were 1,942 male and 1,464 female patients in 12 studies (Table 1) . [7] [8] [9] [10] [11] [16] [17] [18] [19] [21] [22] [23] Co-morbidities
were not reported in any of the studies.
Conversion from laparoscopic to open procedure
Six studies reported conversion of laparoscopic procedures to open procedures. 7, 11, 18, 20, 21, 23 Two of these stated there were no conversions. 11, 23 The pooled data gave the rates of Potentially relevant studies identified through databases and screnned for retrieval n=8,470
Potentially appropriate studies to be included in the analysis n=21
Studies included in analysis with usable information n=13
Inappropriate outcomes n=3
Case series (<10 cases) n=5 (23/1,931) and1.4% (10/694) respectively with a combined risk ratio (RR) of 0.97 (95% CI: 0.46-2.07, p=0.94). Heterogeneity was 0% (Fig 2) .
Recurrence of reflux requiring reoperation
Recurrence was compared in five studies. 8, 9, 18, 20, 23 There was no significant difference in recurrence rate between the BMI <30kg/m 2 and BMI ≥30kg/m 2 groups (3.1% [53/1,698] vs7.5% [40/536] respectively) with a combined RR of 1.99 (95% CI: 0.85-4.65, p=0.11). Heterogeneity was 62% (Fig 3) .
Wrap migration
Four studies compared wrap migration at follow-up review. 9, 11, 18, 20 There was no significant difference in the number of patients who had wrap migration between the BMI <30kg/m 2 and BMI ≥30kg/m 2 groups (1.0% [7/694] vs1.3% [5/396] respectively) with a combined RR of 1.23 (95% CI: 0.37-4.03, p=0.73). Heterogeneity was 0% (Fig 4) .
Operative time
Seven studies reported the mean operative time with range or standard deviation. [7] [8] [9] 18, 20, 21, 23 There was a significant minutes, p=0.002). Heterogeneity was 98% (Fig 5) .
Length of stay
The mean length of hospital stay in both groups was reported in five studies. 9, [18] [19] [20] 23 This was significantly lower in the normal weight group, ranging from 1.09 to 2.2 days compared with a range of 1.08-3.17 days in the obese group (SMD: 1.11 days, 95% CI: -0.16-2.06 days, p=0.020). Heterogeneity was 98% (Fig 6) .
Follow-up duration
The mean or median follow-up duration was reported in 11 studies (Table 2) . [7] [8] [9] 11, [16] [17] [18] [19] [21] [22] [23] The minimum mean followup duration was 14.7 months, 11 the maximum being 96 months. 21 
Type of antireflux surgery
The type of ARS performed was reported in all studies (Table 2 ). In seven of the studies, laparoscopic Nissen fundoplication (LNF) was performed in all patients. 7, 9, 10, 16, 17, 19, 20 Perez et al carried out LNF and Belsey Mark IV procedures, noting that the transthoracic approach in the latter operation was technically easier for obese patients. 8 Although Chisholm et al chose LNF and laparoscopic anterior fundoplication for the majority of their patients, 2% underwent laparoscopic Toupet fundoplication (LTF). 21 
Quality of studies
The quality of the studies was evaluated with the MINORS criteria ( Table 1) . 15 The highest score achieved by a noncomparative study was 12/16. 22 For comparative studies, the highest score was 23/24. 9 Three studies concluded that ARS had a poor outcome in high BMI patients (Table 3) .
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Discussion
Laparoscopic fundoplication is the established gold standard for surgical treatment of GORD. 4, 24 ARS in obese patients is technically challenging owing to body habitus, the abundance of intraperitoneal fat and hepatic hypertrophy. As high BMI is the main precipitating factor for GORD, if it remains untreated, it could theoretically bring about failure of the ARS. Patients with a high BMI are prone to an increased rate of postoperative complications and a lower success rate. 10, 17 Bariatric operations are becoming more common and are associated with low complication rates. Roux-en-Y gastric bypass is the most frequently undertaken bariatric procedure, and it has been shown to be effective in achieving weight loss and also in treating reflux in these patients. 25 Conversely, however, many studies have reported that construction of a sound wrap in obese patients has outcomes that are comparable with those for people with normal BMI in terms of both complications and failure. 9, 11, 18 This review was undertaken to compare outcomes of ARS (operative time, length of stay and conversion rates) as well as complications for normal and high BMI patients. Our meta-analysis included eight prospective trials and five retrospective studies. Eight of these classified BMI into three categories 7, 8, 10, 11, [16] [17] [18] [19] [21] [22] [23] while two studies grouped results by BMI <30kg/m 2 and BMI ≥30kg/m 2 . 9, 20 None of the studies detailed any coexisting co-morbidities for their cohort. Obesity associated cardiovascular, respiratory and endocrine comorbidities carry unique challenges when patients are considered for surgery, and they can influence outcomes.
In this meta-analysis, the mean operative time reported in seven studies was significantly longer for obese patients. Interestingly, conversion rates in six studies were similar for the BMI <30kg/m 2 and BMI ≥30kg/m 2 groups (1.2% vs 1.4% respectively, p=0.94), which may be indicative of the competent laparoscopic skills of the surgeons in these studies and their familiarity with operating on people with raised BMI. Only four studies reported on the occurrence of wrap migration (1.0% for BMI <30kg/m 2 vs 1.3% for BMI ≥30kg/m 2 ) and the difference between the groups was not statistically significant. Follow-up duration was reported in 8 studies with a minimum mean of over 14 months. In seven studies, LNF was carried out on all patients, making it the most common procedure. Perez et al compared the LNF and Belsey Mark IV procedures in 224 patients, reporting that the transthoracic procedure was technically easier in obese patients as it gave good exposure of the hiatus. 8 However, this was associated with a higher recurrence in the obese group. Chisholm et al reported outcomes in 481 patients, the majority of whom underwent LNF (67%) followed by laparoscopic anterior fundoplication (31%) and LTF (2%). 21 The choice of wrap was not influenced by BMI and outcomes were not affected by BMI or sex of the patient. Irino et al undertook 14 LTF and 12 LNF procedures, and found patients with BMI >25kg/m 2 had better outcomes than those with BMI <25kg/m 2 . 22 Obesity was not associated with inferior outcomes when Luketina et al compared the outcomes of LTF (n=58) with LNF (n=22) although it should be noted that the follow-up period was only 12 months. 11 Winslow et al predominantly undertook LNF in their 505 patients, with longer operative times in obese patients.
18
This meta-analysis comprised non-randomised studies as there is a dearth of RCTs on the subject. The inclusion of non-randomised studies in meta-analyses is a matter of ongoing debate. 26 While RCTs are considered the gold standard for evidence-based practice, non-randomised studies are increasingly being included in meta-analyses as both types of studies are associated with their unique strengths and weaknesses. 27 Designed to minimise bias, RCTs can be restrictive in their selection criteria. On the other hand, nonrandomised studies tend to be more representative of patient populations seen in routine clinical practice. 28 The approach of analysing non-randomised studies in a systematic manner through a meta-analysis is becoming more prevalent as the resulting information can play an important role in informing practice and investigation. 
Study limitations
There are several limitations to this review. The included studies were from single centres and were mostly retrospective. None of the studies fulfilled all of the MINORS criteria, 15 meaning that firm conclusions cannot be drawn. The incidence of postoperative symptoms (dysphagia, food intolerance, belching), continued use of medications (proton pump inhibitors, H 2 blockers) and satisfaction scores were not reported adequately in the included studies. Furthermore, caution is advised in the interpretation of the results with respect to very severely obese patients (BMI >40kg/m 2 )
undergoing ARS in clinical practice as all patients with BMI >30kg/m 2 were grouped together in a single obese category in the studies included in our analysis. However, given the lack of currently available literature, our review adds important information on antireflux surgery in obese patients.
Conclusions
Analysis of pooled data revealed that ARS in obese patients with GORD is safe and outcomes are comparable with those for patients with a BMI in the normal range. LNF is the most commonly undertaken procedure in obese patients, with acceptable conversion rates. The mean operative time and mean length of hospital stay were prolonged in the high BMI group but complication and reoperation rates were not significantly higher. Consequently, a high BMI should not be a deterrent to considering ARS for appropriate patients. Laparoscopic ARS is safe but more demanding in obese patients. ARS = antireflux surgery; BMI = body mass index; LNF = laparoscopic Nissen fundoplication
